Literature DB >> 4125828

Antifungal activity of silver sulphadiazine.

T J Wlodkowski, H S Rosenkranz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4125828     DOI： 10.1016/s0140-6736(73)92576-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

1.  Antifungal properties of electrically generated metallic ions.

Authors:  T J Berger; J A Spadaro; R Bierman; S E Chapin; R O Becker
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

2.  A PEGylated fibrin hydrogel-based antimicrobial wound dressing controls infection without impeding wound healing.

Authors:  Joel Gil; Shanmugasundaram Natesan; Jie Li; Jose Valdes; Andrew Harding; Michael Solis; Stephen C Davis; Robert J Christy
Journal:  Int Wound J       Date:  2017-08-02       Impact factor: 3.315

Review 3.  Silver-containing alginate fibres and dressings.

Authors:  Yimin Qin
Journal:  Int Wound J       Date:  2005-06       Impact factor: 3.315

Review 4.  Recent developments in antimycotic chemotherapy.

Authors:  R J Holt
Journal:  Infection       Date:  1974       Impact factor: 3.553

5.  Inactivation of Treponema pallidum by silver sulfadiazine.

Authors:  T W Chang; L Weinstein
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

6.  Mechanism of silver sulfadiazine action on burn wound infections.

Authors:  C L Fox; S M Modak
Journal:  Antimicrob Agents Chemother       Date:  1974-06       Impact factor: 5.191

7.  Prevention of herpes keratoconjunctivitis in rabbits by silver sulfadiazine.

Authors:  T W Chang; L Weinstein
Journal:  Antimicrob Agents Chemother       Date:  1975-12       Impact factor: 5.191

8.  Synergy of nitric oxide and silver sulfadiazine against gram-negative, gram-positive, and antibiotic-resistant pathogens.

Authors:  Benjamin J Privett; Susan M Deupree; Christopher J Backlund; Kavitha S Rao; C Bryce Johnson; Peter N Coneski; Mark H Schoenfisch
Journal:  Mol Pharm       Date:  2010-11-11       Impact factor: 4.939

9.  Properties of silver sulfadiazine-resistant Enterobacter cloacae.

Authors:  H S Rosenkranz; J E Coward; T J Wlodkowski; H S Carr
Journal:  Antimicrob Agents Chemother       Date:  1974-02       Impact factor: 5.191

10.  Topical silver sulphadiazine--a new drug for ocular keratomycosis.

Authors:  M Mohan; S K Gupta; V K Kalra; R B Vajpayee; M S Sachdev
Journal:  Br J Ophthalmol       Date:  1988-03       Impact factor: 4.638
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.